Researchers assess the performance of an artificial intelligence-based risk model for breast cancer screening in Europe.
Vertex says another type 1 diabetes patient is insulin-free in updated data out of EASD
Vertex Pharmaceuticals’ islet cell therapy has produced more promising early data in type 1 diabetes patients, with a third reaching independence from insulin and all